Effects of bariatric surgery on nonalcoholic fatty liver disease: Preliminary findings after 2 years
Article first published online: 29 JAN 2007
Journal of Gastroenterology and Hepatology
Volume 22, Issue 4, pages 510–514, April 2007
How to Cite
Furuya, C. K., De Oliveira, C. P. M. S., De Mello, E. S., Faintuch, J., Raskovski, A., Matsuda, M., Vezozzo, D. C. P., Halpern, A., Garrido, A. B., Alves, V. A. F. and Carrilho, F. J. (2007), Effects of bariatric surgery on nonalcoholic fatty liver disease: Preliminary findings after 2 years. Journal of Gastroenterology and Hepatology, 22: 510–514. doi: 10.1111/j.1440-1746.2007.04833.x
- Issue published online: 20 MAR 2007
- Article first published online: 29 JAN 2007
- Accepted for publication 25 September 2006.
- bariatric surgery;
- fatty liver;
- morbid obesity;
- nonalcoholic steatohepatitis
Background and Aim: Although nonalcoholic fatty liver disease (NAFLD) is very common among morbidly obese patients, the effect of weight loss after bariatric surgery on inflammation and fibrosis related to NAFLD is still a matter of debate. The aim of this study was to evaluate the impact of Roux-en-Y gastric bypass (RYGB) surgery on NAFLD with a follow up of 2 years.
Methods: Eighteen consecutive NAFLD patients with body mass index >40 kg/m2 undergoing gastroplasty with RYGB were enrolled, and wedge liver biopsy was obtained at the operation. After 2 years, these patients underwent percutaneous liver biopsy.
Results: At baseline, 67% of patients had nonalcoholic steatohepatitis (NASH) and 33% had steatosis, according to the NASH Clinical Research Network Scoring System (NAS) for biopsy. Cirrhosis was present in 5.5% of the patients with NASH. After a mean excess weight loss of 60%, steatosis disappeared in 84% and fibrosis disappeared in 75% of the patients. Hepatocellular ballooning disappeared in 50%. A slight lobular inflammatory infiltrate remained in 81%, apparently unrelated to fatty degeneration. As liver biochemical variables had been found within normal limits in 92.3% of patients at initial biopsy, no difference was found 2 years later. Lipid profile and blood sugar plasma concentration were closer to normal in all patients after 2 years (P < 0.05).
Conclusions: Aspects of NAFLD including steatohepatitis improved significantly with massive weight loss at 2 years after RYGB surgery. No patient in this series had progression of hepatic fibrosis.